Dr. Don Williamson M.D. serves as Chief Operating Officer, Executive Vice President of the Company. Prior to being appointed Chief Operating Officer in 2017, Dr. Williamson served as one of our three national Chief Medical Officers since 2011 and as one of our nephrologist partners since 2002. He has more than 25 years of experience as a nephrologist. Prior to his appointment as Chief Operating Officer, he served as President, Chief Executive Officer and Managing Partner for our clinic joint venture Nephrology Associates, P.C. in Augusta, Georgia from 1998 to 2017 and as the Founder and Chief Executive Officer of our clinic joint venture, Nephrology Centers of America, LLC, from 2001 to 2017. He is the Co-Founder and, since 2010, has been the Chief Executive Officer and Managing Partner of Kinetic Decision Solutions LLC, a developer of electronic medical record software. Dr. Williamson received his B.A. in Chemistry from Mercer University and his M.D. from the Medical College of Georgia.
As the Chief Operating Officer e Executive Vice President of American Renal Associates, the total compensation of Don Williamson at American Renal Associates is $1,772,140. There are no executives at American Renal Associates getting paid more.
Don Williamson is 57, he's been the Chief Operating Officer e Executive Vice President of American Renal Associates since 2017. There are 7 older and 4 younger executives at American Renal Associates. The oldest executive at American Renal Associates Holdings Inc. is Robert Fish, 69, who is the Independent Director.
Don's mailing address filed with the SEC is C/O ARAH, INC., 500 CUMMINGS CENTER, SUITE 6550, BEVERLY, MA, 01915.
Over the last 9 years, insiders at American Renal Associates have traded over $0 worth of American Renal Associates stock and bought 2,870 units worth $63,140 . The most active insiders traders include Thomas W Erickson, Joseph A Carlucci, eSyed T Kamal. On average, American Renal Associates executives and independent directors trade stock every 215 days with the average trade being worth of $4,293,860. The most recent stock trade was executed by Joseph A Carlucci on 9 June 2020, trading 416,720 units of ARA stock currently worth $533,402.
American Renal Associates executives and other stock owners filed with the SEC include: